Prevalence of complementary medicine use in a phase 1 clinical trials program
暂无分享,去创建一个
R. Kurzrock | A. Naing | S. Stephen | D. Hong | J. Wheler | G. Falchook | M. Frenkel | S. Fu | C. Chandhasin | X. Lei | Saneese Stephen
暂无分享,去创建一个
R. Kurzrock | A. Naing | S. Stephen | D. Hong | J. Wheler | G. Falchook | M. Frenkel | S. Fu | C. Chandhasin | X. Lei | Saneese Stephen